Skip to main content
Article thumbnail
Location of Repository

POSTER PRESENTATIONS Open Access Resistance to Artesunate + Mefloquine does not

By Louise A Rodrigues, Gisela Henriques and Pedro Cravo

Abstract

Resistance to almost all available anti-malarials poses a large threat for the effective control of Malaria. The only remaining exceptions are the artemisinin (ART) derivatives. However, there is now evidence that appearance of resistance to ART either administered alone or in combination with other anti-malarials may become a reality. Although resistance to treatment is an obstacle for controlling the disease, in many biological models increased drug resistance is often associated with a biological cost. Similarly, in malaria parasites, resistance to anti-malarial drugs such as chloroquine (CQ) [1] and mefloquine (MF) [2] has been reported as causing a reduction in parasite’s fitness associated with lower asexual growth rates and/or reduced transmission efficiency. By using an artesunate (ATN)-resistant parasite, AS-ATN, we have selected a parasite clone (AS-ATNMF-1) which is resistance to the artesunate + mefloquine (ATN + MF) version of Artemisinin Combination Therapy [3]. AS-ATNMF-1 is also resistant to each component of the combination when administered separately. AS-ATNMF-1 was obtained after twentyseven consecutive sub-inoculations of AS-ATN in mice treated with the ATN + MF combination. Since consecutive sub-inoculations into mice have been shown to cause increased virulence in malaria parasites [4], AS-ATN was also sub-inoculated twenty-seven times into untreated mice in parallel. The resulting line was named AS-ATN27P. In order to assess the fitness cost associated with resistance to the combination ATN + MF, AS-ATNMF-1 parasites were grown with the AS-ATN parental clone or with AS-ATN27P within the same host in absence of drug pressure, for 14 days

Year: 2013
OAI identifier: oai:CiteSeerX.psu:10.1.1.352.499
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://citeseerx.ist.psu.edu/v... (external link)
  • ftp://ftp.ncbi.nlm.nih.gov/pub... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.